403 related articles for article (PubMed ID: 7642042)
21. Incidence and prognosis of early primary ventricular fibrillation in acute myocardial infarction--results of the Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto Miocardico (GISSI-2) database.
Volpi A; Cavalli A; Santoro L; Negri E
Am J Cardiol; 1998 Aug; 82(3):265-71. PubMed ID: 9708651
[TBL] [Abstract][Full Text] [Related]
22. Trends in the use of drug therapies in patients with acute myocardial infarction: 1988 to 1992.
Pashos CL; Normand SL; Garfinkle JB; Newhouse JP; Epstein AM; McNeil BJ
J Am Coll Cardiol; 1994 Apr; 23(5):1023-30. PubMed ID: 7908298
[TBL] [Abstract][Full Text] [Related]
23. Long-term effects of intravenous thrombolysis in acute myocardial infarction: final report of the GISSI study. Gruppo Italiano per lo Studio della Streptochi-nasi nell'Infarto Miocardico (GISSI).
Lancet; 1987 Oct; 2(8564):871-4. PubMed ID: 2889079
[TBL] [Abstract][Full Text] [Related]
24. Streptokinase-induced hypotension has no detrimental effect on patients with thrombolytic treatment for acute myocardial infarction. A substudy of the Romanian Study for Accelerated Streptokinase in Acute Myocardial Infarction (ASK-ROMANIA).
Tatu-Chiţoiu G; Teodorescu C; Dan M; Guran M; Căpraru P; Istrăţescu O; Tatu-Chiţoiu A; Bumbu A; Chioncel V; Arvanitopol S; Dorobanţu M
Rom J Intern Med; 2004; 42(3):557-73. PubMed ID: 16366130
[TBL] [Abstract][Full Text] [Related]
25. The importance of timing of thrombolytic therapy as shown in clinical trials.
Pepine CJ
Clin Cardiol; 1990 Aug; 13(8 Suppl 8):VIII12-7. PubMed ID: 2119925
[TBL] [Abstract][Full Text] [Related]
26. Results of the low-dose (20 mg) pravastatin GISSI Prevenzione trial in 4271 patients with recent myocardial infarction: do stopped trials contribute to overall knowledge? GISSI Prevenzione Investigators (Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto Miocardico).
Ital Heart J; 2000 Dec; 1(12):810-20. PubMed ID: 11302109
[TBL] [Abstract][Full Text] [Related]
27. Determinants of 6-month mortality in survivors of myocardial infarction after thrombolysis. Results of the GISSI-2 data base. The Ad hoc Working Group of the Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto Miocardico (GISSI)-2 Data Base.
Volpi A; De Vita C; Franzosi MG; Geraci E; Maggioni AP; Mauri F; Negri E; Santoro E; Tavazzi L; Tognoni G
Circulation; 1993 Aug; 88(2):416-29. PubMed ID: 8339405
[TBL] [Abstract][Full Text] [Related]
28. GISSI trials in acute myocardial infarction. Rationale, design, and results.
Maggioni AP; Franzosi MG; Fresco C; Turazza F; Tognoni G
Chest; 1990 Apr; 97(4 Suppl):146S-150S. PubMed ID: 2182307
[TBL] [Abstract][Full Text] [Related]
29. GISSI trial: early results and late follow-up. Gruppo Italiano per la Sperimentazione della Streptochinasi nell'Infarto Miocardico.
Rovelli F; De Vita C; Feruglio GA; Lotto A; Selvini A; Tognoni G
J Am Coll Cardiol; 1987 Nov; 10(5 Suppl B):33B-39B. PubMed ID: 3312371
[TBL] [Abstract][Full Text] [Related]
30. Epidemiologic variables and outcome of 1972 young patients with acute myocardial infarction. Data from the GISSI-2 database. Investigators of the Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto Miocardico (GISSI-2).
Moccetti T; Malacrida R; Pasotti E; Sessa F; Genoni M; Barlera S; Turazza F; Maggioni AP
Arch Intern Med; 1997 Apr; 157(8):865-9. PubMed ID: 9129546
[TBL] [Abstract][Full Text] [Related]
31. The GISSI-2 trial: premises, results, epidemiological (and other) implications. Gruppo Italiano per lo Studio delia Sopravvivenza nell'Infarto Miocardico.
Fresco C; Franzosi MG; Maggioni AP; Tognoni G
Clin Cardiol; 1990 Aug; 13(8 Suppl 8):VIII32-6. PubMed ID: 1976465
[TBL] [Abstract][Full Text] [Related]
32. Ten-year follow-up of the first megatrial testing thrombolytic therapy in patients with acute myocardial infarction: results of the Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto-1 study. The GISSI Investigators.
Franzosi MG; Santoro E; De Vita C; Geraci E; Lotto A; Maggioni AP; Mauri F; Rovelli F; Santoro L; Tavazzi L; Tognoni G
Circulation; 1998 Dec; 98(24):2659-65. PubMed ID: 9851950
[TBL] [Abstract][Full Text] [Related]
33. [The biochemical, pharmacological and epidemiological reference picture of the GISSI-Prevention. The Gruppo Italiano per lo Studio della Streptochinasi nell'Infarto Miocardico].
Marchioli R; Di Pasquale A
G Ital Cardiol; 1993 Sep; 23(9):933-64. PubMed ID: 8119523
[No Abstract] [Full Text] [Related]
34. Causes of death in patients with acute myocardial infarction treated with angiotensin-converting enzyme inhibitors: findings from the Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto (GISSI)-3 trial.
Pedrazzini G; Santoro E; Latini R; Fromm L; Franzosi MG; Mocetti T; Staszewsky L; Barlera S; Tognoni G; Maggioni AP;
Am Heart J; 2008 Feb; 155(2):388-94. PubMed ID: 18215613
[TBL] [Abstract][Full Text] [Related]
35. Current issues concerning thrombolytic therapy for acute myocardial infarction.
Hennekens CH; O'Donnell CJ; Ridker PM; Marder VJ
J Am Coll Cardiol; 1995 Jun; 25(7 Suppl):18S-22S. PubMed ID: 7775709
[TBL] [Abstract][Full Text] [Related]
36. Predictors of mortality in 6975 patients with chronic heart failure in the Gruppo Italiano per lo Studio della Streptochinasi nell'Infarto Miocardico-Heart Failure trial: proposal for a nomogram.
Barlera S; Tavazzi L; Franzosi MG; Marchioli R; Raimondi E; Masson S; Urso R; Lucci D; Nicolosi GL; Maggioni AP; Tognoni G;
Circ Heart Fail; 2013 Jan; 6(1):31-9. PubMed ID: 23152490
[TBL] [Abstract][Full Text] [Related]
37. Short-term effects of early intravenous treatment with a beta-adrenergic blocking agent or a specific bradycardiac agent in patients with acute myocardial infarction receiving thrombolytic therapy.
Van de Werf F; Janssens L; Brzostek T; Mortelmans L; Wackers FJ; Willems GM; Heidbüchel H; Lesaffre E; Scheys I; Collen D
J Am Coll Cardiol; 1993 Aug; 22(2):407-16. PubMed ID: 8335810
[TBL] [Abstract][Full Text] [Related]
38. Atenolol use and clinical outcomes after thrombolysis for acute myocardial infarction: the GUSTO-I experience. Global Utilization of Streptokinase and TPA (alteplase) for Occluded Coronary Arteries.
Pfisterer M; Cox JL; Granger CB; Brener SJ; Naylor CD; Califf RM; van de Werf F; Stebbins AL; Lee KL; Topol EJ; Armstrong PW
J Am Coll Cardiol; 1998 Sep; 32(3):634-40. PubMed ID: 9741504
[TBL] [Abstract][Full Text] [Related]
39. Cardiac rupture, mortality and the timing of thrombolytic therapy: a meta-analysis.
Honan MB; Harrell FE; Reimer KA; Califf RM; Mark DB; Pryor DB; Hlatky MA
J Am Coll Cardiol; 1990 Aug; 16(2):359-67. PubMed ID: 2142705
[TBL] [Abstract][Full Text] [Related]
40. [The incidence and clinical implications of left ventricular thrombosis in 769 patients with acute myocardial infarct treated with antithrombotics and fibrinolytics].
Boccardi L; Natale E; Minardi G; Tubaro M; Pucci E; Ricci R; Di Segni M; Di Marcotullio G; Malinconico U; Giovannini E
G Ital Cardiol; 1991 Oct; 21(10):1067-73. PubMed ID: 1804744
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
